About: Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California. As of May 18, 2026, Soleno Therapeutics, Inc. operates as a subsidiary of Neurocrine Biosciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Latest price: $53.01 (+0.04%)
Status: Delisted — removed_from_provider. This asset is no longer trading; historical data is shown.
SLNONASDAQSoleno Therapeutics Inc
Loading watchlist status…
Soleno Therapeutics Inc share price
SLNO price activity
Last Price
Change (24hr)
USD (%)
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
SLNO price performance
0%
5D
0%
1M
14.49%
YTD
-32.65%
1Y
SLNO price fundamentals
N/A
Shares Issued
N/A
Earnings Per Share (EPS)
N/A
Dividends Per Share (DPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US-NASDAQ rank
N/ASector Rank
N/ASLNO Market Signals